Pharming Group N.V.
PHGUF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 4.4% | 17.9% | -14.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 92.7% | 90.4% | 89.5% | 86.8% |
| EBITDA | $0 | $0 | -$0 | $0 |
| % Margin | 24.1% | 10.5% | -5.2% | 16.9% |
| Net Income | $0 | $0 | -$0 | $0 |
| % Margin | 7.8% | 5% | -18.6% | 3.9% |
| EPS Diluted | 0.011 | 0.007 | -0.022 | 0.005 |
| % Growth | 61.4% | 131.8% | -540% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | $0 |